These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6312876)

  • 1. Inhibition of feline leukemia virus replication by human leukocyte interferon.
    Jameson P; Essex M
    Antiviral Res; 1983 Aug; 3(2):115-20. PubMed ID: 6312876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human interferon-alpha-and-gamma-mediated inhibition of retrovirus production in the absence of an inhibitory effect on vesicular stomatitis virus and encephalomyocarditis virus replication in RD-114 cells.
    Herz RE; Rubin BY; Sen GC
    Virology; 1983 Feb; 125(1):246-50. PubMed ID: 6299008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the role of the 2'-5'-oligoadenylate synthetase-RNase L pathway in beta interferon-mediated inhibition of encephalomyocarditis virus replication.
    Kumar R; Choubey D; Lengyel P; Sen GC
    J Virol; 1988 Sep; 62(9):3175-81. PubMed ID: 2841470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feline retrovirus induced T-lymphoblastoid cell-line that produces an atypical alpha type of interferon.
    Yamamoto JK; Ho E; Pedersen NC
    Vet Immunol Immunopathol; 1986 Jan; 11(1):1-19. PubMed ID: 3006326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of human leukocyte and immune interferons on the reproduction and cytopathogenic effect of the encephalomyocarditis virus in mice].
    Mentkevich LM; Zhdanova LV; Meshkova EN
    Vopr Virusol; 1984; 29(5):582-5. PubMed ID: 6097046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids.
    Sen GC; Herz R; Davatelis V; Pestka S
    J Virol; 1984 May; 50(2):445-50. PubMed ID: 6200607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant viruses in cells infected with murine sarcoma virus-feline leukemia virus.
    Al-Adhami R; Chapman AL
    J Natl Cancer Inst; 1975 Mar; 54(3):763-66. PubMed ID: 164569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of human recombinant and lymphoblastoid interferons in human and heterologous cell lines.
    Overall JC; Yeh TJ; Kern ER
    J Interferon Res; 1984; 4(4):529-33. PubMed ID: 6094683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of interferon action. Inhibition of vesicular stomatitis virus in human amnion U cells by cloned human leukocyte interferon.
    Masters PS; Samuel CE
    Biochem Biophys Res Commun; 1984 Feb; 119(1):326-34. PubMed ID: 6322781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of siRNA on feline leukemia virus replication in vitro].
    Lehmann M; Weber K; Rauch G; Hofmann-Lehmann R; Hosie MJ; Meli ML; Hartmann K
    Berl Munch Tierarztl Wochenschr; 2015; 128(5-6):209-17. PubMed ID: 26054227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparate response of encephalomyocarditis virus and MM virus to interferon in JLS-V9R cells.
    Czarniecki CW; Allen PT
    Antiviral Res; 1984 Dec; 4(6):351-5. PubMed ID: 6099710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of feline tripartite motif-containing 25 interferes with the late stage of feline leukemia virus replication.
    Koba R; Oguma K; Sentsui H
    Virus Res; 2015 Jun; 204():88-94. PubMed ID: 25913257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline Leukemia Virus (FeLV) Disease Outcomes in a Domestic Cat Breeding Colony: Relationship to Endogenous FeLV and Other Chronic Viral Infections.
    Powers JA; Chiu ES; Kraberger SJ; Roelke-Parker M; Lowery I; Erbeck K; Troyer R; Carver S; VandeWoude S
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A replication-competent feline leukemia virus, subgroup A (FeLV-A), tagged with green fluorescent protein reporter exhibits in vitro biological properties similar to those of the parental FeLV-A.
    Chang Z; Pan J; Logg C; Kasahara N; Roy-Burman P
    J Virol; 2001 Sep; 75(18):8837-41. PubMed ID: 11507228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory.
    Yousefi S; Escobar MR; Gouldin CW
    Am J Clin Pathol; 1985 Jun; 83(6):735-40. PubMed ID: 2988328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus.
    Anderson SL; Carton JM; Lou J; Xing L; Rubin BY
    Virology; 1999 Mar; 256(1):8-14. PubMed ID: 10087221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain.
    Carter CC; Gorbacheva VY; Vestal DJ
    Arch Virol; 2005 Jun; 150(6):1213-20. PubMed ID: 15717119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of interferon action: inhibition of vesicular stomatitis virus replication in human amnion U cells by cloned human leukocyte interferon. I. Effect on early and late stages of the viral multiplication cycle.
    Masters PS; Samuel CE
    J Biol Chem; 1983 Oct; 258(19):12019-25. PubMed ID: 6311834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Feline leukemia virus replication by the integrase inhibitor Raltegravir.
    Cattori V; Weibel B; Lutz H
    Vet Microbiol; 2011 Aug; 152(1-2):165-8. PubMed ID: 21570781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats.
    de Mari K; Maynard L; Sanquer A; Lebreux B; Eun HM
    J Vet Intern Med; 2004; 18(4):477-82. PubMed ID: 15320583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.